Side-effects of resveratrol in HepG2 cells: reduced pten and increased bcl-xl mRNA expression

Min Zheng1, Ruifu Chen, Hongyuan Zhong

  • 1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350108, P.R. China.

Molecular Medicine Reports
|September 14, 2012
PubMed

Insights

Resveratrol inhibits hepatocellular carcinoma (HCC) cell proliferation but does not alter pten or bcl-xl mRNA. This suggests cancer cells develop chemoresistance to resveratrol through a self-protection mechanism.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Resveratrol, found in red grapes and wine, shows potential in treating hepatocellular carcinoma (HCC).
  • High doses of resveratrol may cause adverse side effects.
  • Understanding resveratrol's molecular mechanisms in HCC is crucial.

Purpose of the Study:

  • To investigate the effects of resveratrol on hepatocellular carcinoma (HCC) cell proliferation.
  • To analyze the impact of resveratrol on the mRNA expression of pten and bcl-xl genes in HepG2 cells.

Main Methods:

  • Utilized semi-quantitative and quantitative PCR to assess mRNA expression.
  • Stimulated HepG2 cells with 200 µmol/l resveratrol for 12 hours.
  • Monitored changes in pten and bcl-xl gene expression and cell proliferation.

Main Results:

  • Resveratrol stimulation inhibited HepG2 cell proliferation.
  • Observed a reduction in pten mRNA expression.
  • Detected an increase in bcl-xl mRNA expression.

Conclusions:

  • Resveratrol's anticancer mechanism in HCC does not involve upregulating pten or downregulating bcl-xl.
  • Resveratrol may induce a cellular self-protection response, leading to chemoresistance in HepG2 cells.